Adcock to post loss amid turnaround

Comment on this story
Pharma REUTERS A pharmacist counts pills in a pharmacy.

Johannesburg - Adcock Ingram, South Africa’s largest supplier of hospital products, said it will record a nine-month loss as new management attempts to turn around the company after a failed takeover bid.

The drugmaker will post a basic and headline loss per share in the nine months through June, the Johannesburg-based company said in a statement today.

Changes are being made to the structure of the business and the financial impact is still being assessed, it said.

Adcock was the subject of a 10-month battle for control after profit margins came under pressure from rising production costs and a weaker rand in 2012.

The changes are “unlikely to yield significant improvement in the short term,” Adcock said.

“The board however remains optimistic about the company’s long-term prospects.”

Adcock shares declined 0.4 percent to 52.10 rand as of the market close in Johannesburg, about 31 percent below the high end of a 74.50 rand to 75.78 rand takeover offer by CFR Pharmaceuticals SA of Chile, which collapsed earlier this year.

The stock has declined 27 percent in 2014, making it the fifth-worst performer on the FTSE/JSE Africa All Share Index.

CFR, Chile’s biggest drug maker, called off a 12.8-billion rand cash and stock offer to buy Adcock after Johannesburg-based Bidvest built a blocking stake.

Bidvest chief executive Brian Joffe became Adcock’s new chairman with Kevin Wakeford becoming chief executive. - Bloomberg News

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines